Evidence map›Paper›PMID 36424376›Full record

ArticleBlood cancer journal2022

Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.

Saurabh Zanwar, Matthew Ho, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri and 20 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Saurabh Zanwar *Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-5074-8453
Matthew Ho *Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Francis K BuadiDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-3214-0203
Sikander AilawadhiDivision of Hematology, Mayo Clinic, Jacksonville, FL, USA.ORCID 0000-0002-8377-8111
Jeremy LarsenDivision of Hematology, Mayo Clinic, Scottsdale, AZ, USA.
Leif BergsagelDivision of Hematology, Mayo Clinic, Scottsdale, AZ, USA.ORCID 0000-0003-1523-7388
Moritz BinderDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-9014-9658
Asher Chanan-KhanDivision of Hematology, Mayo Clinic, Jacksonville, FL, USA.
David DingliDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-7477-3004
Angela DispenzieriDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-8780-9512
Rafael FonsecaDivision of Hematology, Mayo Clinic, Scottsdale, AZ, USA.ORCID 0000-0002-5938-3769
Morie A GertzDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-3853-5196
Wilson GonsalvesDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Ronald S GoDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-8284-3495
Suzanne HaymanDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Prashant KapoorDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-4342-364X
Taxiarchis KourelisDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0001-8573-9434
Martha Q LacyDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Nelson LeungDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Yi LinDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-1556-6416
Eli MuchtarDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-2210-2174
Vivek RoyDivision of Hematology, Mayo Clinic, Jacksonville, FL, USA.ORCID 0000-0002-5950-4620
Taimur SherDivision of Hematology, Mayo Clinic, Jacksonville, FL, USA.
Rahma WarsameDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Amie FonderDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Miriam HobbsDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Yi L HwaDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Robert A KyleDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
S Vincent RajkumarDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-5862-1833
Shaji KumarDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. Kumar.Shaji@mayo.edu.ORCID 0000-0001-5392-9284

Funding

Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple MyelomaP50CA186781 · NCI · MAYO CLINIC ARIZONA · PI Peter Leif Bergsagel · 2015 to 2026
$25.5M
NCI NIH HHS P50 CA186781
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Monoclonal Gammopathy of Undetermined SignificanceParaproteinemiasHumans

Identifiers

PMID36424376
PMCPMC9686231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.